High circulating levels of interleukin-18 binding protein indicate the severity of glomerular involvement in systemic lupus erythematosus

References

• Horwitz DA, Jacob CO. The cytokine network in the pathogen-esis of systemic lupus erythematosus and possible therapeutic implications. Springer Semin Immunopathol. 1994;16:181–200.
   PubMed Web of Science ®Google Scholar
• Aringer M, Crow MK. A bridge between interferon-alpha and tumor necrosis factor in lupus. J Rheumatol. 2008;35:1473–6.
   PubMed Web of Science ®Google Scholar
• Dean GS, Tyrrell-Price J, Crawley E, Isenberg DA. Cytokines and systemic lupus erythematosus. Ann Rheum Dis. 2000;59:243–51.
   PubMed Web of Science ®Google Scholar
• Esfandiari E, McInnes IB, Lindop G, Huang FP, Field M, Kornai-Koma M, Wei X, Liew FY. A proinfiammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol. 2001;167: 5338–47.
   Google Scholar
• Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Akita K, Namba M, Tanabe F, KOonishi K, Fukuda S, Kurimoto M. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995;378:88–91.
   PubMed Web of Science ®Google Scholar
• Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol. 1998;10: 259–64.
   Google Scholar
• Wong CK, Li EK, Ho CY, Lam CW. Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus. Rheumatology (Oxf). 2000;39: 1078–81.
   PubMed Web of Science ®Google Scholar
• Aizawa Y, Akita K, Taniai M, Torigoe K, Mori T, Nishida Y, Ushio S, Nukada Y, Tanimoto T, Ikegami H, Ikeda M, Kurimoto M. Cloning and expression of interleukin-18 binding protein. FEBS Lett. 1999;445:338–42.
   PubMed Web of Science ®Google Scholar
• Kim SH, Eisenstein M, Reznikov L, Fantuzzi G, Novick D, Rubinstein M, Dinarello CA. Structural requirements of six nat-urally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA. 2000;97: 1190–5.
   Google Scholar
• Novick D, Schwartsburd B, Pinkus R, Suissa D, Belzer I, Sthoeger Z, Keane WF, Chvatchko Y, Kim SH, Fantuzzi G, Dinarello CA, Rubinstein M. A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine. 2001;14:334–42.
   PubMed Web of Science ®Google Scholar
• Nakamura A, Shikata K, Hiramatsu M, Nakatou T, Kitamura T, Wada J, Itoshima T, Makino H. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care. 2005;28:2890–5.
   PubMed Web of Science ®Google Scholar
• Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, Decker JL, Balow JE. Prognostic factors in lupus nephritis: contribution of renal histologic data. Am J Med. 1983;75: 382–91.
   Google Scholar
• Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA. Nagata M; International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis. The classification of glomerulonephritis in systemic lupus erythema-tosus revisited. Kidney Int. 2004;65:521–30.
   PubMed Web of Science ®Google Scholar
• Tucci M, Quatraro C, Lombardi L, Pellegrino C, Dammacco F, Silvestris F. Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. Arthritis Rheum. 2008;58:251–62.
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised cri-teria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25: 1271–7.
   PubMed Web of Science ®Google Scholar
• Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992;35:630–40.
   Google Scholar
• Konishi K, Tanabe F, Taniguchi M, Yamauchi H, Tanimoto T, Ikeda M, Orita K, Kurimoto M. A simple and sensitive bioassay for the detection of human interleukin-18/interferon-gamma-inducing factor using human myelomonocytic KG-1 cells. J Immunol Methods. 1997;209:187–91.
   PubMed Web of Science ®Google Scholar
• Wong CK, Ho CY, Li EK, Tam LS, Lam CW. Elevated pro-duction of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus. Clin Exp Immunol. 2002;130: 345–51.
   Google Scholar
• Fujita T, Shimizu C, Fuke Y, Satomura A, Abe M, Kaizu K, Matsumoto K, Soma M. Serum interleukin-18 binding protein increases with behavior different from IL-18 in patients with diabetic nephropathy. Diabetes Res Clin Pract. 2011;Mar 25 [Epub ahead of print].
   Google Scholar
• Reddy VS, Harskamp RE, van Ginkel MW, Calhoon J, Baisden CE, Kim IS, Valente AJ, Chandrasekar B. Interleukin-18 stimu-lates fibronectin expression in primary human cardiac fibroblasts via PI3 K-Akt-dependent NF-kappa B activation. J Cell Physiol. 2008;215:697–707.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Novel targets for interleukin 18 binding protein. Ann Rheum Dis. 2001;60\(Suppl 3):iii18–24.
   Google Scholar
• Segerer S, Heller F, Lindenmeyer MT, Schmid H, Cohen CD, Draganovici D, Mandelbaum J, Nelson PJ, Gröne H.T, Gröne EF, Figel AM, Nössner E, Schlöndorff D. Compartment specific expression of dendritic cell markers in human glomerulonephri-tis. Kidney Int. 2008;74:37–46.
   Google Scholar
• Matsumoto K, Fukuda N, Abe M, Fujita T. Dendritic cells and macrophages in kidney disease. Clin Exp Nephrol. 2010;14:1–11.
   PubMed Web of Science ®Google Scholar
• Nicoletti F, Di Marco R, Papaccio G, Conget I, Gomis R, Ber-nardini R, Shoenfeld Y, Bendtzen K. Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insu-litis by a recombinant IL-18-binding protein: Fc construct. Eur J Immunol. 2003;33: 2278–86.
   Google Scholar
• Liang D, Ma W, Yao C, Liu H, Chen X. Imbalance of interleukin 18 and interleukin 18 binding protein in patients with lupus nephritis. Cell Mol Immunol. 2006;3: 303–6.
   Google Scholar
• Leng J, Yao H, Shen J, Wang K, Zhuo G, Wang Z. Co-expression of IL-18 binding protein and IL-4 regulates 'Th1/Th2 cytokine response in murine collagen-induced arthritis. Acta Biochim Biophys Sin (Shanghai). 2008;40:116–24.
   PubMed Web of Science ®Google Scholar
• Mazodier K, Main V, Novick D, Farnarier C, Robitail S, Schleinitz N, Veit V, Paul P, Rubinstein M, Dinarello CA, Harlé JR, Kaplanski G. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood. 2005;106: 3483–9.
   Google Scholar
• Iannello A, Boulassel MR, Samarani S, Tremblay C, Toma E, Routy JP, Ahmad A. HIV-1 causes an imbalance in the produc-tion of interleukin-18 and its natural antagonist in HIV-infected individuals: implications for enhanced viral replication. J Infect Dis. 2010;201: 608–17.
   Google Scholar
• Fujita T, Ogihara N, Kamura Y, Satomura A, Fuke Y, Shimizu C. Wada Y, Matsumoto K. Interleukin-18 contributes more closely to the progression of diabetic nephropathy than other diabetic complications. Acta Diabetol. 2010; Feb 26 [E-pub ahead of print].
   Google Scholar
• Platis A, Yu Q, Moore D, Khojeini E, Tsau P, Larson D. The effect of daily administration of IL-18 on cardiac structure and function. Perfusion. 2008;23:237–42.
   PubMed Web of Science ®Google Scholar
• Weber KT, Brilla CG, Janicki JS, Reddy HK, Campbell SE. Myocardial fibrosis: role of ventricular systolic pressure, arterial hypertension, and circulating hormones. Basic Res Cardiol. 1991;86(Suppl 3):25–31.
   Google Scholar
• Siew ED, Ikizler TA, Gebretsadik T, Shintani A, Wickersham N, Bossed F, Peterson JF, Parikh CR, May AK, Ware LB. Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes. Clin J Am Soc Nephrol. 2010;5:1497–505.
   PubMed Web of Science ®Google Scholar
• Szeto CC, Kwan BC, Lai KB, Lai FM, Chow KM, Wang G, Luk CC, Li PK. Urinary expression of kidney injury markers in renal transplant recipients. Clin J Am Soc Nephrol. 2010;5:2329–37.
   PubMed Web of Science ®Google Scholar